BIVICTRIX
LIVE

Serial Number

79345166

Owner

BIVICTRIX LIMITED

Attorney

Leon R. Legleiter

Filing Date

Feb 22, 2022

Add to watchlist:

No watchlists yet
View on USPTO

BIVICTRIX Trademark

Serial Number: 79345166 • Registration: 7894914

BIVICTRIX is a trademark filed by BIVICTRIX LIMITED on February 22, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

BIVICTRIX LIMITED (3 trademarks)

Mereside Alderlay Park,

Entity Type: 99

Trademark Details

Filing Date

February 22, 2022

Registration Date

August 19, 2025

Published for Opposition

June 3, 2025

Goods & Services

Pharmaceutical preparations, namely, preparations for the treatment of cancer; medical preparations, namely, preparations for the treatment of cancer; veterinary preparations, namely, preparations for the treatment of cancer; anti-cancer drugs; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; biological preparations for medical purposes, namely, for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of cancer; biotechnological preparations for medical use for the treatment of cancer; chemical preparations for medical purposes, namely, for prevention or treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for prevention or treatment of cancer; chemical preparations for pharmaceutical use, namely, for prevention or treatment of cancer; chemotherapeutics; pharmaceutical compounds for treating cancer; drugs for medical purposes for the treatment of cancer; medicines, namely, medicines for cancer disorders; medicines for human purposes, namely, cancer medicines; pharmaceutical compositions, namely, preparations for the treatment of cancer; pharmaceutical drugs, namely, preparations for the treatment of cancer; pharmaceutical preparations and substances, namely, preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, preparations for the treatment of cancer; pharmaceutical preparations for medical purposes, namely, preparations for the treatment of cancer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer

Filing History

FINAL DISPOSITION NOTICE SENT TO IB
Feb 25, 2026 FICS
FINAL DISPOSITION PROCESSED
Feb 25, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 19, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 19, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 3, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 3, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 28, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 30, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 30, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 30, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 30, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 30, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 28, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 30, 2024 GNFN
FINAL REFUSAL E-MAILED
Sep 30, 2024 GNFR
FINAL REFUSAL WRITTEN
Sep 30, 2024 CNFR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 2, 2024 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 7, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 20, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 20, 2023 OPNR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 2, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 2, 2023 GNSL
SUSPENSION LETTER WRITTEN
Oct 2, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 15, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 15, 2023 TROA
REFUSAL PROCESSED BY IB
Mar 6, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 15, 2023 RFCS
REFUSAL PROCESSED BY MPU
Feb 15, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 20, 2022 RFCR
NON-FINAL ACTION WRITTEN
Dec 19, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 6, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 19, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 14, 2022 REPR